Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group

7. Carney DN. The biology of lung cancer. Acta Oncoll989,28, l-5. Linnoila I. Pathology of non-small cell lung cancer. New diagnostic approaches. HematologVlOncologv Clinics of North America 1990,4, 1027-1051. Ariyoshi Y, Kato K, Sugiura T, et al. Therapeutic significance of neurone-specific enolase (NSE) in lung cancer. Proc Am Assoc Clin Oncoll986,5,23 (abstr). Linnoila RI, Jensen S, Steinberg S, et al. Neuroendocrine differentiation in non-small cell lung cancer (NSCLC) correlates wirh favorable response fo chemotherapy. Proc. Am Sot Clin OncoZl989, 8,248. Graziano SL, Mazid R, Newman N, et al. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer. J C/in Oncol 1989, 7, 1298-1406. Broers JLV, Klein Rot M, Oostendorp T, er al. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal and neuroendocrine antigens. Cancer Res 1987,47,3225-3234. with response to combination chemotherapy. Eur J Cancer Clin Oncoll983,19,1365-1370. Hsu SM, Raine L, Franger H. Use of the avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. 3 Histothem Cytochem 1981,29,577-579. Moss F, Bobrow LG, Sheppard MN, et al. Expression of epithelial and neural antigens in small cell and non-small cell lung carcinoma. 3 Patholl986,149,103-111. 10. Kayser K, Schmid W, Ebert W, Wiedenmann B. Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung. Path Res Pratt 1988,183, 412-417. 11.